S D Rountree

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. pmc Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
    Susan D Rountree
    Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, TX 77030, USA
    Alzheimers Res Ther 1:7. 2009
  2. doi request reprint Effectiveness of antidementia drugs in delaying Alzheimer's disease progression
    Susan D Rountree
    Department of Neurology, Alzheimer s Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, USA
    Alzheimers Dement 9:338-45. 2013
  3. pmc Factors that influence survival in a probable Alzheimer disease cohort
    Susan D Rountree
    Alzheimer s Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, 1977 Butler Boulevard, Suite E5, 101, Houston, TX 77030, USA
    Alzheimers Res Ther 4:16. 2012
  4. pmc Predicting progression of Alzheimer's disease
    Rachelle S Doody
    Alzheimer s Disease and Memory Disorders Center, Baylor College of Medicine, 6501 Fannin Street, NB302, Houston, TX 77030, USA
    Alzheimers Res Ther 2:2. 2010
  5. ncbi request reprint Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia
    S D Rountree
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Dement Geriatr Cogn Disord 24:476-82. 2007

Detail Information

Publications5

  1. pmc Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
    Susan D Rountree
    Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, TX 77030, USA
    Alzheimers Res Ther 1:7. 2009
    ..This study examined whether persistent use of antidementia drugs slows clinical progression of Alzheimer disease (AD) assessed by repeated measures on serial tests of cognition and function...
  2. doi request reprint Effectiveness of antidementia drugs in delaying Alzheimer's disease progression
    Susan D Rountree
    Department of Neurology, Alzheimer s Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, USA
    Alzheimers Dement 9:338-45. 2013
    ..Long-term observational controlled studies (LTOCs) extend our understanding by providing longitudinal data across multiple stages of Alzheimer's disease (AD)...
  3. pmc Factors that influence survival in a probable Alzheimer disease cohort
    Susan D Rountree
    Alzheimer s Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, 1977 Butler Boulevard, Suite E5, 101, Houston, TX 77030, USA
    Alzheimers Res Ther 4:16. 2012
    ..This longitudinal study examined multiple factors that influence survival in a cohort of Alzheimer patients followed over two decades...
  4. pmc Predicting progression of Alzheimer's disease
    Rachelle S Doody
    Alzheimer s Disease and Memory Disorders Center, Baylor College of Medicine, 6501 Fannin Street, NB302, Houston, TX 77030, USA
    Alzheimers Res Ther 2:2. 2010
    ..We tested a calculated initial progression rate to see whether it predicted performance on cognition, function and behavior over time, and to see whether it predicted survival...
  5. ncbi request reprint Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia
    S D Rountree
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Dement Geriatr Cogn Disord 24:476-82. 2007
    ..To evaluate baseline characteristics and conversion to dementia in mild cognitive impairment (MCI) subtypes...